CLINICAL TRIALS PROFILE FOR DIENOGEST; ESTRADIOL VALERATE
✉ Email this page to a colleague
All Clinical Trials for DIENOGEST; ESTRADIOL VALERATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00293059 ↗ | Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding | Completed | Bayer | Phase 3 | 2005-12-01 | The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding. |
NCT00307801 ↗ | Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding | Completed | Bayer | Phase 3 | 2006-02-01 | The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding. |
NCT00335218 ↗ | Fat Distribution in Healthy Early Postmenopausal Women | Completed | Bayer | Phase 4 | 2002-07-01 | The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DIENOGEST; ESTRADIOL VALERATE
Condition Name
Clinical Trial Locations for DIENOGEST; ESTRADIOL VALERATE
Trials by Country
Clinical Trial Progress for DIENOGEST; ESTRADIOL VALERATE
Clinical Trial Phase
Clinical Trial Sponsors for DIENOGEST; ESTRADIOL VALERATE
Sponsor Name